US Stock MarketDetailed Quotes

Rani Therapeutics (RANI)

Watchlist
  • 0.9389
  • +0.0234+2.56%
Close Apr 24 16:00 ET
  • 0.9384
  • -0.0005-0.05%
Post 18:44 ET
93.71MMarket Cap-2.09P/E (TTM)

Rani Therapeutics (RANI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
58.85%1.63M
42.12%1.46M
0
0
172K
1.03M
1.03M
0
0
0
Operating revenue
58.85%1.63M
42.12%1.46M
--0
--0
--172K
--1.03M
--1.03M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-21.10%39.94M
-18.55%10M
-38.49%7.26M
-16.12%10.51M
-13.18%12.19M
-23.41%50.63M
-8.65%12.27M
-33.92%11.8M
-31.54%12.52M
-15.03%14.03M
Selling and administrative expenses
-17.57%19.74M
-6.87%5.09M
-28.27%4.04M
-21.98%5M
-12.92%5.62M
-9.55%23.95M
-6.28%5.46M
-15.19%5.63M
-11.08%6.41M
-5.23%6.45M
-General and administrative expense
-17.57%19.74M
-6.87%5.09M
-28.27%4.04M
-21.98%5M
-12.92%5.62M
-9.55%23.95M
-6.28%5.46M
-15.19%5.63M
-11.08%6.41M
-5.23%6.45M
Research and development costs
-24.27%20.21M
-27.91%4.91M
-47.81%3.22M
-9.98%5.51M
-13.39%6.57M
-32.66%26.68M
-10.47%6.81M
-44.99%6.17M
-44.84%6.12M
-21.89%7.59M
Operating profit
22.76%-38.31M
24.09%-8.54M
38.49%-7.26M
16.12%-10.51M
14.40%-12.01M
24.96%-49.6M
16.30%-11.24M
33.92%-11.8M
31.54%-12.52M
15.03%-14.03M
Net non-operating interest income expense
36.88%-2.06M
104.84%37K
28.82%-657K
14.10%-719K
2.68%-725K
-83.30%-3.27M
-23.03%-764K
-93.50%-923K
-126.22%-837K
-135.76%-745K
Non-operating interest income
-53.09%827K
6.67%384K
-83.57%68K
-64.01%158K
-60.29%218K
-46.59%1.76M
-46.67%360K
-50.66%414K
-51.00%439K
-38.38%549K
Non-operating interest expense
-42.56%2.89M
-69.13%347K
-45.77%725K
-31.27%877K
-27.13%943K
-1.02%5.03M
-13.27%1.12M
1.60%1.34M
0.79%1.28M
7.21%1.29M
Other net income (expense)
84.49%-576K
-3.71M
Special income (charges)
84.49%-576K
----
----
----
----
---3.71M
----
----
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--3.71M
----
----
----
----
-Less:Other special charges
--576K
----
----
----
----
----
----
----
----
----
-Write off
--0
----
----
----
----
--3.71M
----
----
----
----
Income before tax
27.63%-40.95M
42.28%-9.07M
37.79%-7.91M
15.99%-11.22M
13.81%-12.74M
16.64%-56.58M
-11.86%-15.72M
30.60%-12.72M
28.41%-13.36M
12.20%-14.78M
Income tax
Net income
27.63%-40.95M
42.28%-9.07M
37.79%-7.91M
15.99%-11.22M
13.81%-12.74M
16.64%-56.58M
-11.86%-15.72M
30.60%-12.72M
28.41%-13.36M
12.20%-14.78M
Net income continuous Operations
27.63%-40.95M
42.28%-9.07M
37.79%-7.91M
15.99%-11.22M
13.81%-12.74M
16.64%-56.58M
-11.86%-15.72M
30.60%-12.72M
28.41%-13.36M
12.20%-14.78M
Minority interest income
57.55%-11.28M
118.17%1.23M
57.87%-2.5M
30.87%-4.53M
24.97%-5.47M
21.66%-26.57M
2.62%-6.78M
34.99%-5.94M
29.96%-6.56M
13.76%-7.3M
Net income attributable to the parent company
1.15%-29.67M
-15.18%-10.31M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
11.63%-30.02M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.81M
10.62%-7.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.15%-29.67M
-15.18%-10.31M
20.21%-5.41M
1.66%-6.69M
2.93%-7.26M
11.63%-30.02M
-26.05%-8.95M
26.25%-6.78M
26.85%-6.81M
10.62%-7.48M
Basic earnings per share
57.14%-0.45
74.07%-0.07
50.00%-0.12
30.77%-0.18
24.14%-0.22
21.05%-1.05
0.00%-0.27
33.33%-0.24
29.73%-0.26
12.12%-0.29
Diluted earnings per share
57.14%-0.45
74.07%-0.07
50.00%-0.12
30.77%-0.18
24.14%-0.22
21.05%-1.05
0.00%-0.27
33.33%-0.24
29.73%-0.26
12.12%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 58.85%1.63M42.12%1.46M00172K1.03M1.03M000
Operating revenue 58.85%1.63M42.12%1.46M--0--0--172K--1.03M--1.03M--0--0--0
Cost of revenue
Gross profit
Operating expense -21.10%39.94M-18.55%10M-38.49%7.26M-16.12%10.51M-13.18%12.19M-23.41%50.63M-8.65%12.27M-33.92%11.8M-31.54%12.52M-15.03%14.03M
Selling and administrative expenses -17.57%19.74M-6.87%5.09M-28.27%4.04M-21.98%5M-12.92%5.62M-9.55%23.95M-6.28%5.46M-15.19%5.63M-11.08%6.41M-5.23%6.45M
-General and administrative expense -17.57%19.74M-6.87%5.09M-28.27%4.04M-21.98%5M-12.92%5.62M-9.55%23.95M-6.28%5.46M-15.19%5.63M-11.08%6.41M-5.23%6.45M
Research and development costs -24.27%20.21M-27.91%4.91M-47.81%3.22M-9.98%5.51M-13.39%6.57M-32.66%26.68M-10.47%6.81M-44.99%6.17M-44.84%6.12M-21.89%7.59M
Operating profit 22.76%-38.31M24.09%-8.54M38.49%-7.26M16.12%-10.51M14.40%-12.01M24.96%-49.6M16.30%-11.24M33.92%-11.8M31.54%-12.52M15.03%-14.03M
Net non-operating interest income expense 36.88%-2.06M104.84%37K28.82%-657K14.10%-719K2.68%-725K-83.30%-3.27M-23.03%-764K-93.50%-923K-126.22%-837K-135.76%-745K
Non-operating interest income -53.09%827K6.67%384K-83.57%68K-64.01%158K-60.29%218K-46.59%1.76M-46.67%360K-50.66%414K-51.00%439K-38.38%549K
Non-operating interest expense -42.56%2.89M-69.13%347K-45.77%725K-31.27%877K-27.13%943K-1.02%5.03M-13.27%1.12M1.60%1.34M0.79%1.28M7.21%1.29M
Other net income (expense) 84.49%-576K-3.71M
Special income (charges) 84.49%-576K-------------------3.71M----------------
-Less:Impairment of capital assets ----------------------3.71M----------------
-Less:Other special charges --576K------------------------------------
-Write off --0------------------3.71M----------------
Income before tax 27.63%-40.95M42.28%-9.07M37.79%-7.91M15.99%-11.22M13.81%-12.74M16.64%-56.58M-11.86%-15.72M30.60%-12.72M28.41%-13.36M12.20%-14.78M
Income tax
Net income 27.63%-40.95M42.28%-9.07M37.79%-7.91M15.99%-11.22M13.81%-12.74M16.64%-56.58M-11.86%-15.72M30.60%-12.72M28.41%-13.36M12.20%-14.78M
Net income continuous Operations 27.63%-40.95M42.28%-9.07M37.79%-7.91M15.99%-11.22M13.81%-12.74M16.64%-56.58M-11.86%-15.72M30.60%-12.72M28.41%-13.36M12.20%-14.78M
Minority interest income 57.55%-11.28M118.17%1.23M57.87%-2.5M30.87%-4.53M24.97%-5.47M21.66%-26.57M2.62%-6.78M34.99%-5.94M29.96%-6.56M13.76%-7.3M
Net income attributable to the parent company 1.15%-29.67M-15.18%-10.31M20.21%-5.41M1.66%-6.69M2.93%-7.26M11.63%-30.02M-26.05%-8.95M26.25%-6.78M26.85%-6.81M10.62%-7.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.15%-29.67M-15.18%-10.31M20.21%-5.41M1.66%-6.69M2.93%-7.26M11.63%-30.02M-26.05%-8.95M26.25%-6.78M26.85%-6.81M10.62%-7.48M
Basic earnings per share 57.14%-0.4574.07%-0.0750.00%-0.1230.77%-0.1824.14%-0.2221.05%-1.050.00%-0.2733.33%-0.2429.73%-0.2612.12%-0.29
Diluted earnings per share 57.14%-0.4574.07%-0.0750.00%-0.1230.77%-0.1824.14%-0.2221.05%-1.050.00%-0.2733.33%-0.2429.73%-0.2612.12%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More